VANGUARD GROUP INC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$367,270,076
-23.1%
8,903,517
+4.2%
0.01%
-18.2%
Q2 2023$477,353,601
-2.6%
8,548,596
-2.7%
0.01%
-8.3%
Q1 2023$490,038,215
+59.7%
8,783,621
+4.3%
0.01%
+50.0%
Q4 2022$306,825,200
+30.2%
8,420,011
+1.8%
0.01%
+14.3%
Q3 2022$235,654,000
-33.5%
8,274,359
+5.7%
0.01%
-30.0%
Q2 2022$354,205,000
-39.8%
7,827,758
+1.2%
0.01%
-28.6%
Q1 2022$588,213,000
-47.7%
7,732,523
+2.4%
0.01%
-46.2%
Q4 2021$1,125,251,000
+1.6%
7,554,042
-0.7%
0.03%
-3.7%
Q3 2021$1,106,997,000
-20.1%
7,604,044
+7.4%
0.03%
-20.6%
Q2 2021$1,386,321,000
+17.3%
7,079,569
+8.4%
0.03%
+6.2%
Q1 2021$1,181,629,000
+34.9%
6,528,337
+5.5%
0.03%
+28.0%
Q4 2020$876,179,000
+18.0%
6,187,705
+3.9%
0.02%0.0%
Q3 2020$742,397,000
+110.0%
5,954,418
+50.4%
0.02%
+92.3%
Q2 2020$353,469,000
+422.9%
3,957,771
+264.9%
0.01%
+333.3%
Q1 2020$67,599,000
-15.0%
1,084,716
+4.0%
0.00%0.0%
Q4 2019$79,509,000
+116.9%
1,042,739
+43.3%
0.00%
+200.0%
Q3 2019$36,662,000727,4270.00%
Other shareholders
10X GENOMICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Venrock Management VI, LLC 8,185,565$952,538,00099.56%
Foresite Capital Management I, LLC 2,750,000$342,870,00096.54%
Foresite Capital Management II, LLC 3,503,528$436,820,00095.05%
12 West Capital Management LP 1,922,000$239,635,00011.66%
FINANCIAL CONSULATE, INC 163,366$20,368,0009.67%
JS Capital Management LLC 606,400$75,606,0003.91%
Asymmetry Capital Management, L.P. 43,512$5,425,0003.49%
Pinz Capital Management, LP 55,400$6,907,0002.52%
HAMILTON LANE ADVISORS LLC 37,087$4,624,0002.24%
RTW INVESTMENTS, LP 660,933$82,405,0001.98%
View complete list of 10X GENOMICS INC shareholders